Researchers have identified three genes that play a role in vision loss in multiple sclerosis (MS), possibly paving the way for the development of precision medicine for the condition.
The study by Johns Hopkins Medicine singled out the three ‘complement system’ genes, which are already known to be integral in the brain and immune system’s development, using people with MS’s DNA and retinal scanning. Further studies are needed, but it’s hoped these genes could serve as markers for monitoring and predicting the severity and progression of MS.
The researchers say they hope this discovery may one day lead to bespoke designer therapies, similar to how new cancer treatments are being developed.
Source: MS-UK 05/11/2019